Locally Advanced/Recurrent or Distant Metastasized Non-small Cell Lung Cancer With MET Overexpression
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer (NCT06525350) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2024-07-01 |
Track Locally Advanced/Recurrent or Distant Metastasized Non-small Cell Lung Cancer With MET Overexpression automatically
Every clearance here is in the API, with alerts when new ones post.